WOODCLIFF LAKE, NJ, September 21, 2020-

PDI, a global leader in infection prevention products and solutions, today announced that Super Sani-Cloth^® wipes, the number one disinfecting wipe in healthcare, received approval for the SARS-CoV-2 efficacy claim from the United States Environmental Protection Agency (EPA). 

The EPA approval expanded the label claims for Super Sani-Cloth wipes (EPA Reg No. 9480-4) to include deactivation of SARS-CoV-2, the virus that causes COVID-19, after one minute of contact time on hard, nonporous surfaces. Before a product can legally make efficacy claims against a particular pathogen, the claim must be approved by the EPA based on a thorough review of scientific data. According to the data provided by PDI Healthcare, the Super Sani-Cloth wipes caused a 3-log reduction against the SARS-CoV-2 virus, which meets the EPA's efficacy requirements. Prior to receiving approval for this claim, Super Sani-Cloth wipes were included on EPA's List N entitled "Disinfectants for Use Against SARS-CoV-2."

Nonwovens Markets subscribers - click here to read the full article.

Not a subscriber?

Try Nonwovens Markets free!